Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood.v80.8.2081.bloodjournal8082081PMID 1391960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of membrane gangliosides in the binding and action of bacterial toxins

  2005cited by this paper
• Somatic cell hybridisation studies showing different gene mutations in Niemann-Pick variants

  2004cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15.1----p15.4.

  1991cited by this paper
• Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs.

  1991cited by this paper
• Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.

  1991cited by this paper
• Niemann-Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients.

  1991cited by this paper
• Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients.

  1991cited by this paper
• A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein

  1990cited by this paper
• Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.

  1990cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis

  1989cited by this paper
• Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

  1989cited by this paper
• Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts.

  1989cited by this paper
• Functions of sphingolipids and sphingolipid breakdown products in cellular regulation.

  1989cited by this paper
• Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

  1989cited by this paper
• The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.

  1989cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis.

  1989cited by this paper
• A leucine‐to‐proline mutation in the insulin receptor in a family with insulin resistance.

  1989cited by this paper
• Natural history and inherited disorders of a lysosomal enzyme, beta-hexosaminidase.

  1989cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.

  1988cited by this paper
• Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.

  1988cited by this paper
• Sphingomyelinases and Niemann-Pick disease.

  1986cited by this paper
• Enzyme activities and phospholipid storage patterns in brain and spleen samples from niemann-pick disease variants: a comparison of neuropathic and non-neuropathic forms

  1986cited by this paper
• Immunological Studies on Acidic Sphingomyelinase

  1986cited by this paper
• Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

  1985cited by this paper
• Studies on the Activation of Sphingomyelinase Activity in Niemann-Pick Type A, B, and C Fibroblasts: Enzymological Differentiation of Types A and B

  1984cited by this paper
• Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression

  1982cited by this paper
• Affinity purification of alpha-galactosidase A from human spleen, placenta, and plasma with elimination of pyrogen contamination. Properties of the purified splenic enzyme compared to other forms.

  1981cited by this paper
• Acidic phospholipases in cultured human fibroblasts: deficiency of phospholipase C in Niemann-Pick disease.

  1980cited by this paper
• Genetic Disorders Among the Jewish People

  1980cited by this paper
• Tay-Sachs disease: genetic drift among the Ashkenazim Jews.

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Synthesis of 2-n-(hexadecanoyl)-amino-4-nitrophenyl phosphorylcholine-hydroxide, a chromogenic substrate for assaying sphingomyelinase activity.

  1976cited by this paper
• Controversy in human genetics: founder effect in Tay-Sachs disease.

  1972cited by this paper
• Founder effect in Tay-Sachs disease unlikely.

  1972cited by this paper
• Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease.

  1967cited by this paper
• The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae.

  1966cited by this paper
• THE CEREBRAL DEFECT IN TAY‐SACHS DISEASE AND NIEMANN‐PICK DISEASE *

  1961cited by this paper

• Current and Emerging Treatments for Acid Sphingomyelinase Deficiency

  2025cites this paper
• Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk

  2024cites this paper
• The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann–Pick Disease: A Comprehensive Review

  2024cites this paper
• Exome sequencing in Asian populations identifies rare deficient SMPD1 alleles that increase risk of Parkinson's disease

  2023cites this paper
• Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)

  2023cites this paper
• Case report: The spectrum of SMPD1 pathogenic variants in Hungary

  2023cites this paper
• In Silico Analysis of the Molecular-Level Impact of SMPD1 Variants on Niemann-Pick Disease Severity

  2021influential citation
• Emerging links between pediatric lysosomal storage diseases and adult parkinsonism

  2019cites this paper
• Deep sequencing of SMPD1 gene revealed a heterozygous frameshift mutation (p.Ser192Alafs) in a Palestinian infant with Niemann–Pick disease type A: a case report

  2018cites this paper
• Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)

  2017cites this paper
• Tay Sachs Disease: Analysis Of Australian Screening Strategies (1995-2013)

  2016cites this paper
• Systematic Genetic Analysis of the SMPD1 Gene in Chinese Patients with Parkinson’s Disease

  2016cites this paper
• SMPD1 Mutation Update: Database and Comprehensive Analysis of Published and Novel Variants

  2016cites this paper
• Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A

  2016cites this paper
• EXPLORING THE ROLE OF MITOCHONDRIAL CHOLESTEROL IN NIEMANN-PICK TYPE C DISEASE

  2016cites this paper
• SMPD1 mutations and Parkinson disease.

  2015cites this paper
• Four Novel p.N385K, p.V36A, c.1033–1034insT and c.1417–1418delCT Mutations in the Sphingomyelin Phosphodiesterase 1 (SMPD1) Gene in Patients with Types A and B Niemann-Pick Disease (NPD)

  2015cites this paper
• Co-option of Membrane Wounding Enables Virus Penetration into Cells.

  2015cites this paper
• [Niemann-Pick disease--a rare disease in children's hepatology (a clinical case)].

  2014cites this paper
• Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease

  2013cites this paper
• The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease

  2013cites this paper
• Functional Implications of Novel Human Acid Sphingomyelinase Splice Variants

  2012cites this paper
• Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms

  2011cites this paper
• The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.

  2009cites this paper
• [A case of a Korean adult affected by type B Niemann-Pick disease: secondary sea-blue histiocytosis and molecular characterization].

  2009cites this paper
• Carrier frequency of autosomal‐recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?

  2008cites this paper
• Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.

  2008cites this paper
• Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.

  2007cites this paper
• The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann–Pick disease

  2007cites this paper
• Novel aspects of molecular biology and pathology of lysosomal storage disorders.studies with partial use of Caenorhabditis elegans

  2007cites this paper
• Identification and Expression of a Missense Mutation ( Y 446 C ) in the Acid Sphingomyelinase Gene from a Japanese Patient with Type A Niemann-Pick Disease

  2006cites this paper
• Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease.

  2006cites this paper
• TYPE B NIEMANN-PICK DISEASE: REPORT OF A CASE WITH MILIARY PATTERN ON CHEST X-RAY

  2005cites this paper
• Functional in vitro characterization of 14 SMPD1 mutations identified in Italian patients affected by Niemann Pick Type B disease

  2005cites this paper
• DNA-based carrier screening in the Ashkenazi Jewish population

  2004cites this paper
• A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase

  2004cites this paper
• The Natural History of Type B Niemann-Pick Disease: Results From a 10-Year Longitudinal Study

  2004cites this paper
• based on its remote structural homolog purple acid phosphatase A model of the acid sphingomyelinase phosphoesterase domain data

  2004cites this paper
• Lipid abnormalities in children with types A and B Niemann Pick disease.

  2004cites this paper
• Acid sphingomyelinase: Identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in‐frame start codon

  2004cites this paper
• Screening of 25 Italian patients with Niemann‐Pick a reveals fourteen new mutations, one common and thirteen private, in SMPD1

  2004cites this paper
• Growth restriction in children with type B Niemann-Pick disease.

  2003cites this paper
• Seven Novel Acid Sphingomyelinase Gene Mutations in Niemann‐Pick Type A and B Patients

  2003cites this paper
• Carrier Testing for Autosomal- Recessive Disorders

  2003cites this paper
• The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype/phenotype correlations.

  2002cites this paper
• Molecular epidemiology of Tay-Sachs disease.

  2001cites this paper
• Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.

  2001cites this paper
• Molecular basis of mendelian disorders among Jews.

  2000cites this paper
• Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype

  1998cites this paper
• Niemann Pick disease type A in Israeli Arabs: 677delT, a common novel single mutation

  1998cites this paper
• Sphingomyelinases in cell regulation.

  1997cites this paper
• Temporal bone histopathology of Niemann-Pick disease type A.

  1997cites this paper
• Niemann–Pick Disease: Mutation Update, Genotype/Phenotype Correlations, and Prospects for Genetic Testing

  1997influential citation
• Identification of three novel mutations in the acid sphinogomyelinase gene of Japanese patients with Niemann-Pick disease type A and B.

  1996cites this paper
• Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease.

  1995cites this paper
• Identification and expression of a missense mutation (Y446C) in the acid sphingomyelinase gene from a Japanese patient with type A Niemann-Pick disease.

  1995cites this paper
• Lysosomal storage diseases.

  1995cites this paper
• Two new mutations in the acid sphingomyelinase gene causing type a Niemann–Pick disease: N389T and R441X

  1995cites this paper
• Accurate Differentiation of Neuronopathic and Nonneuronopathic Forms of Niemann‐Pick Disease by Evaluation of the Effective Residual Lysosomal Sphingomyelinase Activity in Intact Cells

  1994cites this paper
• A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate

  1994cites this paper